Literature DB >> 17956927

Community acquired MRSA in Europe.

Tristan Ferry, Jerome Etienne.   

Abstract

Mesh：

Year:  2007        PMID： 17956927      PMCID： PMC2072037          DOI： 10.1136/bmj.39373.465903.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003.

Authors:  J Robert; J Etienne; X Bertrand
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

2.  Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.

Authors:  Jörg J Ruhe; Nathaniel Smith; Robert W Bradsher; Anupama Menon
Journal:  Clin Infect Dis       Date:  2007-02-01       Impact factor: 9.079

3.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Authors:  Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

4.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

5.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

6.  Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin.

Authors:  Oana Dumitrescu; Sandrine Boisset; Cedric Badiou; Michele Bes; Yvonne Benito; Marie-Elisabeth Reverdy; François Vandenesch; Jerome Etienne; Gerard Lina
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

7.  Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.

Authors:  Ulrich Seybold; Ekaterina V Kourbatova; James G Johnson; Sue J Halvosa; Yun F Wang; Mark D King; Susan M Ray; Henry M Blumberg
Journal:  Clin Infect Dis       Date:  2006-01-25       Impact factor: 9.079

8.  Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.

Authors:  Miriam Wiese-Posselt; Dagmar Heuck; Andreas Draeger; Martin Mielke; Wolfgang Witte; Andrea Ammon; Osamah Hamouda
Journal:  Clin Infect Dis       Date:  2007-04-25       Impact factor: 9.079

9.  Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece.

Authors:  V Chini; E Petinaki; A Foka; S Paratiras; G Dimitracopoulos; I Spiliopoulou
Journal:  Clin Microbiol Infect       Date:  2006-01       Impact factor: 8.067

10.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more
  8 in total

1.  Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung".

Authors:  Mark D Ebert; Sheila Sheth; Elliot K Fishman
Journal:  Emerg Radiol       Date:  2008-02-15

2.  Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006.

Authors:  Mari Kanerva; Saara Salmenlinna; Jaana Vuopio-Varkila; Pirkko Lehtinen; Teemu Möttönen; Mikko J Virtanen; Outi Lyytikäinen
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

3.  First autochthonous familial cluster of invasive community-acquired leukocidin-positive methicillin-resistant USA300 Staphylococcus aureus in France.

Authors:  Philippe Traore; Nadège Bourgeois-Nicolaos; Raymond Ruimy; Frédéric Laurent; Philippe Labrune; Florence Doucet-Populaire; Jean-Winoc Decousser
Journal:  Folia Microbiol (Praha)       Date:  2014-05-24       Impact factor: 2.099

4.  Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey.

Authors:  B Lamy; F Laurent; O Gallon; F Doucet-Populaire; J Etienne; J-W Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

Review 5.  The treatment of diabetic foot infections: focus on ertapenem.

Authors:  Michael Edmonds
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

Review 6.  Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.

Authors:  Georgios Kalambokis; Areti Theodorou; Paraskevi Kosta; Epameinondas V Tsianos
Journal:  Int J Hematol       Date:  2008-05-21       Impact factor: 2.490

7.  A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections.

Authors:  Inge C Gyssens; Matthew Dryden; Peter Kujath; Dilip Nathwani; Nicolaas Schaper; Barbara Hampel; Peter Reimnitz; Jeff Alder; Pierre Arvis
Journal:  J Antimicrob Chemother       Date:  2011-09-06       Impact factor: 5.790

8.  Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries.

Authors:  Petra Dickmann; Sam Keeping; Nora Döring; Andrea E Schmidt; Claudia Binder; Sergio Ariño-Blasco; Joan Gil
Journal:  Front Public Health       Date:  2017-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.